SEC Comment Letter 0000000000-24-009118 to Replimune Group, Inc. (REPL) (CIK 0001737953) (REPL)
Replimune Group, Inc. (REPL) (CIK 0001737953)
Date: Aug. 9, 2024 · CIK: 0001737953 · Accession: 0000000000-24-009118
AI Filing Summary & Sentiment
File numbers found in text: 333-281358
Letter
August 9, 2024 Sushil Patel Chief Executive Officer Replimune Group, Inc. 500 Unicorn Park Drive 3rd Floor Woburn MA 01801 Re:Replimune Group, Inc. Registration Statement on Form S-3 Filed August 8, 2024 File No. 333-281358 Dear Sushil Patel: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Daniel Crawford at 202-551-7767 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc:Tim Corbet, Esq.
Show Raw Text
August 9, 2024
Sushil Patel
Chief Executive Officer
Replimune Group, Inc.
500 Unicorn Park Drive
3rd Floor
Woburn MA 01801
Re:Replimune Group, Inc.
Registration Statement on Form S-3
Filed August 8, 2024
File No. 333-281358
Dear Sushil Patel:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that
the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Daniel Crawford at 202-551-7767 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:Tim Corbet, Esq.